EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of CENPM as a key gene driving adrenocortical carcinoma metastasis via physical interaction with immune checkpoint ligand FGL1

Cunru Zou, Yu Zhang, Chengyue Liu, Yaxin Li, Congjie Lin, Hao Chen, Jiangping Hou, Guojun Gao, Zheng Liu, Qiupeng Yan, Wenxia Su iD

Clinical and Translational Medicine · 2025

DOI: 10.1002/ctm2.70182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2025. Verfasst von Cunru Zou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, School of Basic Medicine, Shandong Second Medical University, Weifang, China. Hauptthemen laut MEDLINE: Adrenocortical Carcinoma, Adrenal Cortex Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Distant metastasis occurs in the majority of adrenocortical carcinoma (ACC), leading to an extremely poor prognosis. However, the key genes driving ACC metastasis remain unclear.

Methods

Weighted gene co‐expression network analysis (WGCNA) and functional enrichment analysis were conducted to identify ACC metastasis‐related genes. Data from RNA‐seq and microarray were analyzed to reveal correlations of the CENPM gene with cancer, metastasis, and survival in ACC. Immunohistochemistry was used to assess CENPM protein expression. The impact of CENPM on metastasis behaviour was verified in ACC (H295R and SW‐13) cells and xenograft NPG mice. DIA quantitative proteomics analysis, western blot, immunofluorescence, and co‐immunoprecipitation assay were performed to identify the downstream target of CENPM.

Results

Among the 12 035 analyzed genes, 363 genes were related to ACC metastasis and CENPM was identified as the hub gene. CENPM was upregulated in ACC samples and associated with metastasis and poor prognosis. Knockdown of CENPM inhibited proliferation, invasion, and migration of ACC cells and suppressed liver metastasis in xenograft NPG mice. Collagen‐containing extracellular matrix signalling was primarily downregulated when CENPM was knocked down. FGL1, important components of ECM signalling and immune checkpoint ligand of LAG3, were downregulated following CENPM silence, overexpressed in human advanced ACC samples, and colocalized with CENPM. Physical interaction between CENPM and FGL1 was identified. Overexpression of FGL1 rescued migration and invasion of CENPM knockdown ACC cells.

Conclusions

CENPM is a key gene in driving ACC metastasis. CENPM promotes ACC metastasis through physical interaction with the immune checkpoint ligand FGL1. CENPM can be used as a new prognostic biomarker and therapeutic target for metastatic ACC. Highlights CENPM is the key gene that drives ACC metastasis, and a robust biomarker for ACC prognosis. Silencing CENPM impedes ACC metastasis in vitro and in vivo by physical interaction with immune checkpoint ligand FGL1. FGL1 is overexpressed in ACC and promotes ACC metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenocortical CarcinomaAdrenal Cortex NeoplasmsHumansMiceAnimalsNeoplasm MetastasisPrognosisCell Line, TumorGene Expression Regulation, NeoplasticFemale

Stichwörter der Autor:innen

CENPMFGL1adrenocortical carcinomametastasis

Autor:innen und Institutionen

  • Department of Physiology, School of Basic Medicine, Shandong Second Medical University, Weifang, China.
  • Department of Pathology, Affiliated Hospital of Shandong Second Medical University, Weifang, China.
  • Department of Ophthalmology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • Department of Urology Surgery, Affiliated Hospital of Shandong Second Medical University, Weifang, China.
  • Department of Urology Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • Department of Teaching and Research Section of Introduction to Basic Medicine, School of Basic Medicine, Shandong Second Medical University, Weifang, China.

ORCID-Profile: Wenxia Su

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Zou, C., Zhang, Y., Liu, C., Li, Y., Lin, C., Chen, H., Hou, J., Gao, G., Liu, Z., Yan, Q., & Su, W. (2025). Identification of CENPM as a key gene driving adrenocortical carcinoma metastasis via physical interaction with immune checkpoint ligand FGL1. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70182

Vancouver

Zou C, Zhang Y, Liu C, Li Y, Lin C, Chen H, et al. Identification of CENPM as a key gene driving adrenocortical carcinoma metastasis via physical interaction with immune checkpoint ligand FGL1. Clinical and Translational Medicine. 2025. doi:10.1002/ctm2.70182

BibTeX
@article{Zou2025,
  author = {Zou, Cunru and Zhang, Yu and Liu, Chengyue and Li, Yaxin and Lin, Congjie and Chen, Hao and Hou, Jiangping and Gao, Guojun and Liu, Zheng and Yan, Qiupeng and Su, Wenxia},
  title = {Identification of CENPM as a key gene driving adrenocortical carcinoma metastasis via physical interaction with immune checkpoint ligand FGL1},
  journal = {Clinical and Translational Medicine},
  year = {2025},
  doi = {10.1002/ctm2.70182}
}
Kostenlos starten →